Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
PHARMTECH.COM
CPhI.COM
INGREDIENTS
MANUFACTURING
OUTSOURCING
  Pharmaceutical Technology Europe E-Alert
 
8 October 2014
Visit PharmTech
at Stand 5D81
• About CPhI
 • CPhI Pharma Awards
 • News/Events


 
CPhI Day 2

Representatives of the global pharmaceutical industry will convene in Paris on 7-9 October for CPhI 2014, the annual exhibition of products, services, and equipment for pharmaceutical formulation, development, and manufacturing.

The editors of Pharmaceutical Technology Europe preview the event in this special edition of the E-Alert.

Meet this year's CPhI Pharma Awards Winners
Celebrating the best of pharma and recognizing companies that turn inspiration into innovation. More...
 
CPhI Releases Part 2 of their Annual Industry Report
CPhI released Part 2 of their annual industry report focused on the future of the pharmaceutical industry. More...
 
Norbrook Presents API and Finished Products Portfolio at CPhI
Norbrook Laboratories will be showcasing its portfolio of APIs and its range of Norbrook Finished Product at CPhI Worldwide 2014. More...
 
Molecular Profiles Launches New Development Platform at CPhI
This year's CPhI sees Molecular Profiles launching its ROADMAP to Clinical Trials screening platform. More...
 
Focus on Biosimilars
The total market for biopharmaceuticals in 2013 was $36.8 billion according to Kalorama Information. Meanwhile, Frost & Sullivan estimates that the biosimilars market, which it pegged at just $1.2 billion in 2013, will grow to $23 billion in 2019, or more than 20-fold increase. More...
 
 
Milan API Producer Opens High-Potent API Plant
LABOCHIM SpA completes construction on multipurpose high-potent API plant in Milan. More...
 
Almac Expands its UK Commercial Packaging Facility
Almac expands its blister-packaging suite to meet the needs of two Japanese clients. More...
 
Podcast
User-Friendly Dosage Forms—The Future of Oral Drug Delivery
Thomas Hein, PhD, director, Business Development and Regulatory Affairs, Hermes Pharma, speaks with PharmTech about the problems associated with conventional tablets and capsules and discusses the advantages offered by innovative user-friendly dosage forms. More...
Focus on Pharmaceutical Development
Investigation of Various Impurities in Febuxostat
Febuxostat is a novel, non-purine, selective inhibitor of xanthine oxidase for hyperuricemia in patients with gout. It is the first promising substitute for allopurinol in 40 years. Various synthetic routes to febuxostat, as well as polymorphic forms and impurities of the drug, are reported in the literature. More...
 
Outsourcing Grows in Europe
Eric Langer of BioPlan Associates describes the development of biopharmaceutical outsourcing in Europe over the past 25 years. More...
 
Protecting Drug Safety
In the past 10 years, safety issues have become increasingly important in pharmaceutical packaging, from needle-sticking safety to counterfeit protection. More...
 
Opportunities with Softgels
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies. More...
 
Product Profiles
Powder Systems Ltd
Visit us as P-MEC Hall 1 Booth 1C69

PSL simplefilter now with agitator
Now with agitation, the revolutionary simplefilter from PSL simplifies your filtration and drying process, available in PFA coated carbon steel or in 316L stainless steel and Alloy 22 as options. Learn more


Contact Us

Click here to contact editorial.

Click here to contact sales.